J. F. Fuster Soler

Neuroblastoma: validation of the INRG classification system in a small series

M. B. Bermúdez Cortés, A. G. Galera Miñarro, E. Ramos Elbal, 2019, Clinical and Translational Oncology.

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

A. Borobia, H. Tong, M. Blanquer, 2020, BMJ Open.

The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia

Bernadette J. Stolz, B. Stolz, H. Byrne, 2021, medRxiv.

Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia

C. Beaumont, Érica Morán, B. Grandchamp, 2011, Haematologica.

[Autologous «blood patch» pleurodesis: A safe and useful treatment for persistent pneumothorax in children].

S. R. Reyes Domínguez, M. C. León León, Á. Navarro Mingorance, 2016, Anales de pediatria.

[Neonatal tumours and congenital malformations].

O. Soldin, J. O. Ortega García, J. Ferrís i Tortajada, 2008, Anales de pediatria.

[Mycophenolate mofetil: an alternative treatment for refractory autoimmune hemolytic anemia in children].

A. G. Galera Miñarro, Á. Navarro Mingorance, J. F. Fuster Soler, 2012, Anales de pediatria.

Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL-Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia.

A. Borobia, A. Navarro, A. Balas, 2021, Clinical lymphoma, myeloma & leukemia.

Pharmacoepidemiological study of drug–drug interactions in onco-hematological pediatric patients

G. Ruíz Merino, M. Á. Fernández de Palencia Espinosa, J. F. Fuster Soler, 2014, International Journal of Clinical Pharmacy.